ImageneBio, Inc. Common Stock

IMANASDAQ • USD
4.97 USD
↘ 0.08 (1.58%)AT CLOSE (11:59 AM EDT)
4.91
↘ 0.06 (1.23%)
POST MARKET (AS OF 04:02 PM EDT)
Post Market
AS OF 04:02 PM EDT
4.91
↘ 0.06 (1.23%)
🔴Market: CLOSED
Open?$4.90
High?$5.10
Low?$4.90
Prev. Close?$5.05
Volume?14.5K
Avg. Volume?36.2K
VWAP?$5.05
Rel. Volume?0.40x
Bid / Ask
Bid?$4.66 × 100
Ask?$5.14 × 200
Spread?$0.48
Midpoint?$4.90
Valuation & Ratios
Market Cap?55.6M
Shares Out?10.7M
Float?8.5M
Float %?79.8%
P/E Ratio?N/A
P/B Ratio?0.40
EPS?-$4.09
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?13.24Strong
Quick Ratio?13.24Strong
Cash Ratio?9.26Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A▾
P/B?
0.40CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
0.7CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-32.7%WEAK▾
ROA?
-28.4%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-47572575
Related Companies
Loading...
News
Profile
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Employees
15
Market Cap
55.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.imagenebio.com
Listed
2025-07-28
Address
12526 HIGH BLUFF DRIVE
SAN DIEGO, CA 92130
Phone: 857-343-8292
MarketsMoversWatchlist